Interferon-α and the calcifying microangiopathy in Aicardi–Goutières syndrome

Annals of Clinical and Translational Neurology

Volumn 2, Issue 7, 2015, Pages 774-779

  Klok, Melanie D ^a   Bakels, Hannah S ^a   Postma, Nienke L ^a   van Spaendonk, Rosalina M L ^a   van der Knaap, Marjo S ^a,b   Bugiani, Marianna ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

AICARDI GOUTIERES SYNDROME; ARTICLE; BASAL GANGLION; BLOOD VESSEL CALCIFICATION; CELL COUNT; CELL DENSITY; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FEMALE; GENETIC ANALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MICROANGIOPATHY; MINERALIZATION; NEUROPATHOLOGY; PLEOCYTOSIS; PRIORITY JOURNAL; RISK FACTOR;

EID: 84962974222     PISSN: None     EISSN: 23289503     Source Type: Journal    
DOI: 10.1002/acn3.213     Document Type: Article

References (20)

1. Aicardi J, Goutières F. A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. Ann Neurol 1984;15:49–54.
2. Crow YJ. Aicardi-Goutières syndrome. Handb Clin Neurol 2013;113:1629–1635.
3. Hofer MJ, Campbell IL. Type I interferon in neurological disease-the devil from within. Cytokine Growth Factor Rev 2013;24:257–267.
4. Diamond J. Autosomal dominant IFIH1 gain-of-function mutations cause Aicardi-Goutières syndrome. Clin Genet 2014;86:473–474.
5. Barth PG, Walter A, van Gelderen I. Aicardi-Goutières syndrome: a genetic microangiopathy? Acta Neuropathol 1999;98:212–216.
6. Goutières F, Aicardi J, Barth PG, et al. Aicardi-Goutières syndrome: an update and results of interferon-alpha studies. Ann Neurol 1998;44:900–907.
7. Kumar D, Rittey C, Cameron AH, et al. Recognizable inherited syndrome of progressive central nervous system degeneration and generalized intracranial calcification with overlapping phenotype of the syndrome of Aicardi and Goutières. Am J Med Genet 1998;75:508–515.
8. Kevelam SH, Bugiani M, Salomons GS, et al. Exome sequencing reveals mutated SLC19A3 in patients with an early-infantile, lethal encephalopathy. Brain 2013;136:1534–1543.
9. Bugiani M, Postma N, Polder E, et al. Hyaluronan accumulation and arrested oligodendrocyte progenitor maturation in vanishing white matter disease. Brain 2013;136:209–222.
10. Proudfoot D, Shanahan C. Human vascular smooth muscle cell culture. Methods Mol Biol 2012;806:251–263.
11. Reynolds JL, Joannides AJ, Skepper JN, et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004;15:2857–2867.
12. Jones HC, Keep RF. Brain interstitial fluid calcium concentration during development in the rat: control levels and changes in acute plasma hypercalcaemia. Physiol Bohemoslov 1988;37:213–216.
13. Bonewald LF, Harris SE, Rosser J, et al. von Kossa staining alone is not sufficient to confirm that mineralization in vitro represents bone formation. Calcif Tissue Int 2003;72:537–547.
14. Proudfoot D, Skepper JN, Hegyi L, et al. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 2000;87:1055–1062.
15. Rubinstein M, Levy WP, Moschera JA, et al. Human leukocyte interferon: isolation and characterization of several molecular forms. Arch Biochem Biophys 1981;210:307–318.
16. Hobbs DS, Pestka S. Purification and characterization of interferons from a continuous myeloblastic cell line. J Biol Chem 1982;257:4071–4076.
17. van Heteren JT, Rozenberg F, Aronica E, et al. Astrocytes produce interferon-alpha and CXCL10, but not IL-6 or CXCL8, in Aicardi-Goutières syndrome. Glia 2008;56:568–578.
18. Chen NX, Moe SM. Vascular calcification: pathophysiology and risk factors. Curr Hypertens Rep 2012;14:228–237.
19. Akwa Y, Hassett DE, Eloranta ML, et al. Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. J Immunol 1998;161:5016–5026.
20. Pulliero A, Marengo B, Longobardi M, et al. Inhibition of the de-myelinating properties of Aicardi-Goutières syndrome lymphocytes by cathepsin D silencing. Biochem Biophys Res Commun 2013;430:957–962.